The peroxisome proliferator-activated receptor alpha agonist fenofibrate has no effect on insulin sensitivity compared to atorvastatin in type 2 diabetes mellitus; a randomised, double-blind controlled trial. - Black RN; Ennis CN; Young IS; Hunter SJ; Atkinson AB; Bell PM (Journal of diabetes and its complications, 2014)